IPEC: Updated Qualification-Guide published
Recommendation

23-25 November 2026
ICH Q7 in modern API Manufacturing – what to do and how to do
IPEC Europe (International Pharmaceutical Excipients Council Europe) has published the updated Version 3 of the “Qualification of Excipients for Use in Pharmaceuticals: Guide & Checklist” on its website. First published in 2008, this guide provides recommendations for good practices in a risk-based process for qualifying excipients from new or existing suppliers. It supports the establishment of effective relationships between suppliers and users, facilitates the smooth use of excipients, and helps ensure compliance with regulatory and GMP requirements. The guide includes a checklist for identifying the essential information required to qualify excipients used in medicinal products.
Additional Section on Nitrosamines
The key substantive change in Version 3 (2026) compared with Version 2 (2020) is the inclusion of a dedicated section on nitrosamines (2.4.6.5). This section clarifies that nitrosamine risk assessments for finished medicinal products should take excipients into account, even where there is no explicit regulatory obligation for excipient manufacturers to test for nitrites or nitrosamines or to communicate relevant data. Version 3 also refers to an IPEC Nitrosamines Template to support the exchange of information.
The complete document is available on the IPEC website and can be downloaded after registration.
Related GMP News
26.10.2026EMA and CMDh Expand List of Nitrosamine Limits
20.10.2026IPEC Publishes Version 3 of the Excipient Composition Guide
14.10.2026EMA Reports inconsistent Progress in International API Inspection Cooperation
23.09.2026FDA Warning Letter: serious GMP Deficiencies at a Chinese API Manufacturer
16.09.2026PFAS restriction: Commission highlights Importance of critical Medical Applications


